The Prevalence and Characteristics of Psoriatic Arthritis in Patients With Psoriasis in a Tertiary Hospital

Çınar, Nilay Kılıç; Bodur, Hatice; Eser, Filiz; Gül, Ülker; Gönül, Müzeyyen; Oğuz, İşıl Deniz

doi:10.5606/archrheumatol.2015.4454

Cited by 7 publications

(7 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is reported that arthritis may develop in 13–71% of patients before the emergence of skin lesions even though in most patients, arthritis develops after psoriasis skin lesions occur [7, 8]. …”

Section: Introductionmentioning

confidence: 99%

“…Psoriatic arthritis is an inflammatory arthritis that can occur both in the peripheral joints and axial skeleton and is seen in 6–42% of psoriasis patients that have a negative rheumatoid factor [ 5 , 6 ]. It is reported that arthritis may develop in 13–71% of patients before the emergence of skin lesions even though in most patients, arthritis develops after psoriasis skin lesions occur [ 7 , 8 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis

Kılıç¹,

Reşorlu²,

Işık³

et al. 2017

pdia

View full text Add to dashboard Cite

IntroductionMean platelet volume (MPV) is an important marker that shows the activation and function of the platelets, which is effective in the inflammatory diseases.AimTo show the relationship between MPV and the development of psoriatic arthritis (PA) in patients with psoriasis vulgaris (PV) and the correlation between MPV and psoriasis severity score (PASI).Material and methodsOur study included 116 patients with psoriatic arthritis (68 female, 48 male) and 41 patients in the psoriasis group (19 female, 22 male) and 90 subjects in the control group (55 female, 35 male). The demographic data of the patients, duration of disease, PASI, the nature of the disease were evaluated retrospectively.ResultsMean platelet volume levels of both the PV group (8.79 ±0.86 fl) and the PA group (9.18 ±1.26 fl) were significantly higher compared to the control group (8.42 ±0.74 fl). There was a weak statistically positive correlation between the PASI and the MPV according to the correlation analysis (r = 0.165; p = 0.046).ConclusionsOur results show that MPV may be helpful as an indicator of the clinical course of PV and PA. In this regard, that study should be supported by prospective studies to find strong correlations.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis

Kılıç¹,

Reşorlu²,

Işık³

et al. 2017

pdia

View full text Add to dashboard Cite

show abstract

“…Of the 29 articles included in our final analysis, three studies assessed the extent of skin disease in Pso-PsA patients and the later development of PsA (PASI n = 2, affected sites n = 1). The other 26 studies reported psoriasis severity and the presence of PsA in Pso-PsA and PsA patients: either seven studies, selection bias could have been introduced by patient selection (Choi et al [13]; Cinar et al [14]; Haroon et al [15]; Henes et al [16]; Jamshidi et al [17]; Leijten et al [18]; Truong et al [19]), as they assessed previously undiagnosed PsA in cohorts of psoriasis patients (online suppl. Table S3: detailed study characteristics).…”

Section: Search Resultsmentioning

confidence: 99%

“…Concerning studies that investigated psoriasis severity and the presence of PsA, the overall quality was low. In seven studies, selection bias could have been introduced by patient selection (Choi et al [ 13 ]; Cinar et al [ 14 ]; Haroon et al [ 15 ]; Henes et al [ 16 ]; Jamshidi et al [ 17 ]; Leijten et al [ 18 ]; Truong et al [ 19 ]), as they assessed previously undiagnosed PsA in cohorts of psoriasis patients (online suppl. Table S3 : detailed study characteristics).…”

Section: Resultsmentioning

confidence: 99%

Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis

et al. 2022

View full text Add to dashboard Cite

Background: Early identification of patients at risk of psoriatic arthritis (PsA) is essential to facilitate early diagnosis and improve clinical outcomes. Severe cutaneous psoriasis has been proposed to be associated with PsA, but a recent assessment of the evidence is lacking. Therefore, in this systematic review, we address the association of psoriasis skin severity with the presence and development of PsA. Summary: We included articles from a review published in 2014 and supplemented these with recent literature by performing an additional systematic search to identify studies published between 1 January 2013 and 11 February 2021. A meta-analysis was performed when sufficient comparable evidence was available. Of 2,000 screened articles, we included 29 in the analysis, of which 16 were identified by our updated search. Nineteen studies reported psoriasis severity as psoriasis area and severity index (PASI), ten studies as body surface area (BSA), and two studies as “number of affected sites.” Most studies show that more extensive skin disease is associated with the presence of PsA. The quantitative pooled analyses demonstrate higher PASI (mean difference [Δ] 1.59; 95% confidence interval [CI] 0.29–2.89) and higher BSA (Δ 5.31; 95% CI 1.78–8.83) in patients with PsA as compared to psoriasis patients without PsA. Results from prospective studies – that assess the risk of future development of PsA in psoriasis patients – were inconclusive. Key Messages: In patients with psoriasis, more severe skin involvement is associated with the presence of PsA, underpinning the importance of optimal dermatology-rheumatology collaboration in clinical care. There are insufficient data to support the use of psoriasis skin severity to predict the future development of PsA in psoriasis patients.

show abstract

“…Moreover, Henes et al [ 24 ] documented a 30% prevalence of PsA in 404 patients with psoriasis in Germany (multicenter study). In a similar Turkish hospital-based study, 32 patients (25.4%) out of 126 psoriasis patients had PsA [ 25 ]. Moreover, Ranza et al [ 26 ] reported a prevalence of 33% of PsA in a large number of Brazilian psoriasis patients.…”

Section: Discussionmentioning

confidence: 99%

Psoriatic arthritis among Egyptian patients with psoriasis attending the dermatology clinic: prevalence, comorbidities, and clinical predictors

El-Garf¹,

Teleb²,

Said³

et al. 2021

Reumatologia

View full text Add to dashboard Cite

Objectives: Early diagnosis and treatment of psoriatic arthritis (PsA) help to prevent progressive joint involvement and disabilities. There is a problem in the early diagnosis of PsA worldwide, which may be attributed to the dermatologists missing PsA symptoms and signs and a lack of effective screening tools. Aim of the study: The current study was designed to assess the prevalence, comorbidities, and clinical predictors associated with the development of PsA in psoriasis patients. Material and methods: A cross-sectional observational study was performed. Screening questionnaires -the Psoriasis Epidemiology Screening Tool (PEST) and Early Arthritis for Psoriatic Patients (EARP) -were applied to 200 psoriasis patients; among them n = 22 (11% of all tested patients) were in developmental age. Those with positive questionnaires were classified as having PsA or not according to the classification for psoriatic arthritis criteria. Body surface area, psoriasis area and severity index, and psoriasis disability index tools were used for assessing psoriasis patients. A full rheumatological and dermatological evaluation were carried out for PsA patients. Results: The prevalence of PsA was found to be 30%, with a mean age of 45.48 ±10.79 years. Further, psoriasis preceded the onset of PsA in 46 patients (76.6%), arthritis began before psoriasis in 6 individuals (10%), and both psoriasis and arthritis coincided in 8 (13.3%) patients. Obesity (OR 7.0, 95% CI: 2.61-18.85), nail psoriasis (OR 5.02, 95% CI: 2.02-12.476), and intergluteal cleft site (OR 12.659, were associated with increased risk of PsA. However, classic plaque psoriasis (OR 0.149, 95% CI: 0.051-0.433) and flexure site (OR 0.238, 95% CI: 0.076-0.746) were linked with a decreased risk of PsA development. Conclusions: Screening for PsA in patients with psoriasis revealed a significant number of undiagnosed cases of PsA that should be treated early. Obesity, nail psoriasis, and psoriasis at the intergluteal sites can help predict the PsA development.

show abstract

The Prevalence and Characteristics of Psoriatic Arthritis in Patients With Psoriasis in a Tertiary Hospital

Cited by 7 publications

References 23 publications

Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis

Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis

Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis

Psoriatic arthritis among Egyptian patients with psoriasis attending the dermatology clinic: prevalence, comorbidities, and clinical predictors

Contact Info

Product

Resources

About